Pharmacologic management of adult depression

American Family Physician

Volumn 77, Issue 6, 2008, Pages

  Adams, Stephen M ^a,b   Miller, Karl E ^a   Zylstra, Robert G ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BUSPIRONE; CIPROFLOXACIN; CITALOPRAM; CLONIDINE; DESIPRAMINE; DIAZEPAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUOXETINE PLUS OLANZAPINE; FLUVOXAMINE MALEATE; IMIPRAMINE; LAMOTRIGINE; LEVOTHYROXINE; LIOTHYRONINE SODIUM; METOPROLOL SUCCINATE; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PHENYTOIN; QUETIAPINE; RISPERIDONE; SELEGILINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE;

AGITATION; ANOREXIA; ANXIETY; ASTHENIA; ATAXIA; BLOOD PRESSURE; BLURRED VISION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITIVE THERAPY; CONFUSION; CONSTIPATION; DEPRESSION; DIAPHORESIS; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG COMBINATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG INTERACTION; DRUG METABOLISM; DRUG MONITORING; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DYSPEPSIA; DYSURIA; EJACULATION DISORDER; ELECTROCONVULSIVE THERAPY; FATIGUE; FEMALE SEXUAL DYSFUNCTION; FOLLOW UP; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HOSTILITY; HUMAN; HYPERTENSION; HYPOMANIA; HYPOTENSION; IMPOTENCE; INSOMNIA; IRRITABILITY; LETHAL DOSE; LETHARGY; MAJOR DEPRESSION; MALE SEXUAL DYSFUNCTION; MANIA; MEMORY DISORDER; MENTAL PATIENT; NAUSEA; ORTHOSTATIC HYPOTENSION; PARESTHESIA; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARYNGITIS; PRIAPISM; PRURITUS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QT PROLONGATION; RECEPTOR BLOCKING; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SUICIDAL IDEATION; SUICIDE; SWEATING; SYNCOPE; TACHYCARDIA; TASTE DISORDER; TINNITUS; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; TREMOR; URTICARIA; VERTIGO; VISUAL DISORDER; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA; ADULT;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; TREATMENT OUTCOME;

EID: 42449114843     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Leon AC, Olfson M, Broadhead WE, et al. Prevalence of mental disorders in primary care. Implications for screening. Arch Fam Med. 1995;4(10):857-861.
2. Goodwin RD, Kroenke K, Hoven CW, Spitzer RL. Major depression, physical illness, and suicidal ideation in primary care. Psychosom Med. 2003;65(4):501-505. (Pubitemid 36900239)
3. National Center for Health Statistics. Health, United States, 2005 with chartbook on trends in the health of Americans. Hyattsville, Md: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2005. http://www.cdc.gov/nchs/data/hus/hus05.pdf. Accessed September 25, 2007.
4. Thompson Micromedex Drugdex Drug database. http://www.micromedex.com/ products/drugdex/. Accessed September 25, 2007.
5. Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med. 2005;143(6):415-426. (Pubitemid 41341413)
6. Moncrieff J, Wessely S, Hardy R. Active placeboes versus antidepressants for depression. Cochrance Database Syst Rev. 2004;(1):CD003012.
7. Arroll B, Macgillivray S, Ogston S, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med. 2005;3(5):449-456. (Pubitemid 41512663)
8. Trivedi MH, Rush AJ, Wisniewski SR, et al.; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurementbased care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. (Pubitemid 43050100)
9. Potter WZ, Hollister LE. Antidepressant agents. In: Katzung BG. Basic and Clinical Pharmacology. 9th ed. New York, NY: Lange Medical Books/McGraw-Hill; 2004:482-495.
10. Ereshefsky L. Antidepressant pharmacodynamics, pharmacokinetics, and drug interactions. Geriatrics. 1998;53(suppl 4):S22-S33. (Pubitemid 28566589)
11. Furukawa T, McGuire H, Barbui C. Low dosage tricyclic antidepressants for depression. Cochrane Database Syst Rev. 2003;(3):CD003197.
12. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279(4):287-291. (Pubitemid 28071019)
13. Dalton SO, Johansen C, Mellemkjaer L, Norgård B, Sorensen HT, Olsen JH. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study. Arch Intern Med. 2003;163(1):59-64. (Pubitemid 36091601)
14. American Psychiatric Association. Practice guidelines. http://www. psych.org/psych-pract/treatg/pg/prac-guide.cfm. Accessed October 8, 2007.
15. Linde K, Mulrow CD, Berner M, Egger M. St. John's wort for depression. Cochrane Database Syst Rev. 2005;(2):CD000448.
16. Gartlehner G, Hansen RA, Thieda P, et al. Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression. Comparative Effectiveness Review No. 7. Rockville, Md.: Agency for Healthcare Research and Quality, 2007. http://effectivehealthcare.ahrq.gov/ repFiles/Antidepressants-Final-Report. pdf. Accessed January 15, 2008.
17. Guaiana G, Barbui C, Hotopf M. Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev. 2003;(2): CD004186.
18. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163(1):101-108. (Pubitemid 43050110)
19. Keller MB. Issues in treatment-resistant depression. J Clin Psychiatry. 2006;66(suppl 8):5-12. (Pubitemid 43004170)
20. Mann JJ. The medical management of depression. N Engl J Med. 2005;353(17):1819-1834. (Pubitemid 41549894)
21. Institute for Clinical Systems Improvement. Health care guideline: major depression in adults in primary care. 10th ed. 2007. http://www.icsi. org/depression-5/depression-major-in-adults-in-primary-care-3.html. Accessed January 15, 2008.
22. Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci. 2000;25(3):255-261. (Pubitemid 30641002)
23. Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet. 2006;367(9505):153-167. (Pubitemid 43077130)
24. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58(3):241-247. (Pubitemid 32209678)
25. Nelson JC. Tricyclic and heterocyclic drugs. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Publishing Textbook of Psychopharmacology. 3rd ed. Washington, DC: American Psychiatric Pub; 2004:207-230.
26. Rush AJ, Trivedi MH, Wisniewski SR, et al.; STAR*D Study Team. Bupropion- SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354(12):1231-1242.
27. Trivedi MH, Fava M, Wisniewski SR, et al.; STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006; 354(12):1243-1252.
28. Shelton RC, Williamson DJ, Corya SA, et al. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance. J Clin Psychiatry. 2005;66(10):1289-1297. (Pubitemid 41546509)
29. Nemeroff CB. Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psychiatry. 2005;(66 suppl 8):13-21. (Pubitemid 43004171)
30. Andersen SW, Clemow DB, Corya SA. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder. J Clin Psychiatry. 2005;66(11):1468-1476. (Pubitemid 41779547)
31. Salzman C. A 60-year-old woman who has felt sad for much of her life. JAMA. 2006;295(3):318-323. (Pubitemid 43112961)
32. Furukawa TA, Streiner DL, Young LT. Antidepressant plus benzodiazepine for major depression. Cochrane Database Syst Rev. 2001;(2): CD001026.
33. Boyer EW, Shannon M. The serotonin syndrome [published correction appears in N Engl J Med. 2007;356(23):2437]. N Engl J Med. 2005;352(11):1112-1120.
34. Juurlink DN, Mamdani MM, Kopp A, Redelmeier DA. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. Am J Psychiatry. 2006;163(5):813-821. (Pubitemid 44464528)
35. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review [published correction appears in BMJ. 2006;333(7557):30]. BMJ. 2005;330(7488):385.
36. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998;49(1):59-72. (Pubitemid 28139098)
37. DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medication versus cognitive behavior therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. Am J Psychiatry. 1999;156(7):1007-1013. (Pubitemid 29302791)
38. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):409-416. (Pubitemid 40471690)
39. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161(10):1872-1876. (Pubitemid 39314682)
40. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry. 2005;62(4):417-422. (Pubitemid 40471691)
41. de Mello MF, de Jesus Mari J, Bacaltchuk J, Verdeli H, Neugebauer R. A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders. Eur Arch Psychiatry Clin Neurosci. 2005;255(2):75-82. (Pubitemid 40575662)